$1.550
-0.067 (-4.32%)終値時点
OKYO の同業比較
In the context of the broader market, OKYO competes directly with industry leaders such as KLRS and RLYB. With a market capitalization of $81.34M, it holds a significant position in the sector. When comparing efficiency, OKYO's gross margin of N/A stands against KLRS's N/A and RLYB's 100.00%. Such benchmarking helps identify whether OKYO Pharma Ltd is trading at a premium or discount relative to its financial performance.
OKYO Pharma Ltd の財務パフォーマンス
The company has a negative P/E ratio of -6.26 and a price-to-sales ratio of 0, indicating it is not generating revenue relative to its market cap, which is concerning for long-term viability.
Financials
No data
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。